Cost-Effectiveness of Smoking Cessation Among Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer

Is motivation and problem-solving (MAPS), a smoking cessation intervention tested in a randomized clinical trial for survivors of cervical intraepithelial neoplasia or cervical cancer, cost effective?This economic evaluation of 194 participants found that MAPS was cost effective compared with standard treatment for survivors of cervical intraepithelial neoplasia or cervical cancer, using 7-day self-reported point prevalence abstinence as the primary end point and benchmarking against other smoking cessation interventions for patients with cancer.Evidence from this economic analysis suggests scaling up the implementation of MAPS.

Corresponding Author: Ya-Chen Tina Shih, PhD, Department of Radiation Oncology and Jonsson Comprehensive Cancer Center, School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-6900 (tinashih@mednet.ucla.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.